Decreased plasma levels of clusterin in patients with psoriasis;Disminución de los niveles plasmáticos de clusterina en pacientes con psoriasis

Actas Dermo-Sifiliograficas

Volumn 104, Issue 6, 2013, Pages 497-503

  Garcia Rodriguez S ^b   Arias Santiago, S ^a   Perandres Lopez R ^b   Orgaz Molina, J ^a   Castellote, L ^a   Buendia Eisman A ^a   Ruiz, J C ^a   Naranjo, R ^a   Navarro, P ^b   Sancho, J ^b   Zubiaur, M ^b  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Carotid intima media thickness; Clusterin; Macrophage migration inhibitory factor; Psoriasis

Indexed keywords

CLUSTERIN; MIGRATION INHIBITION FACTOR;

ARTICLE; ATHEROMATOSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; HUMAN; METABOLIC SYNDROME X; PROTEIN BLOOD LEVEL; PSORIASIS;

EID: 84879463706     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2012.11.018     Document Type: Article

References (30)

1. D.G. Federman, M. Shelling, S. Prodanovich, C.G. Gunderson, and R.S. Kirsner Psoriasis: an opportunity to identify cardiovascular risk Br J Dermatol 160 2009 1 7
2. M.A. Alsufyani, A.K. Golant, and M. Lebwohl Psoriasis and the metabolic syndrome Dermatol Ther 23 2010 137 143
3. A.M. Tobin, D.J. Veale, O. Fitzgerald, S. Rogers, P. Collins, and D. O'Shea Cardiovascular disease and risk factors in patients with psoriasis and psoriasis arthritis J Reumatol 37 2010 1386 1394
4. W.J. Choi, E.J. Park, I.H. Kwon, K.H. Kim, and K.J. Kim Association between psoriasis and cardiovascular risk factors in Korean patients Ann Dermatol 22 2010 300 306
5. M.A. Gonzalez-Gay, C. Gonzalez-Juanatey, T.R. Vazquez-Rodriguez, I. Gomez-Acebo, J.A. Miranda-Filloy, and J. Paz-Carreira Asymptomatic hyperuricemia and serum uric acid concentrates correlate with subclinical atherosclerosis in psoriasis arthritis patients without clinically evident cardiovascular disease Semin Arthritis Rheum 39 2009 157 162
6. D.D. Balci, A. Balci, S. Karazincir, E. Ucar, U. Iyigun, and F. Yalcin Increased carotid artery intima-media thickness and impaired endothelial function in Psoriasis J Eur Acad Dermatol Venereol 23 2009 1 6
7. S. El-Mongy, H. Fathy, A. Abdelaziz, E. Omran, S. George, and N. Neseem Subclinical atherosclerosis in patients with chronic psoriasis: a potential association J Eur Acad Dermatol Venereol 24 2010 661 666
8. L.E. French, A. Chonn, D. Ducrest, B. Baumann, D. Belin, and A. Wohlwend Murine clusterin: molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis J Cell Biol 122 1993 1119 1130
9. B.J. Aronow, S.D. Lund, T.L. Brown, J.A. Harmony, and D.P. Witte Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection Proc Natl Acad Sci USA 90 1993 725 729
10. S.E. Jones, and C. Jomary Clusterin Int J Biochem Cell Biol 34 2002 427 431
11. H.A. Marianna, G.K. Anastasios, E.S. Konstantinos, P.T. Ioannis, and S.P. Issidora Apolipoprotein J/clusterin is a novel structural component of human erythrocytes and biomarker of cellular stress and senescence Plos One 6 2011 e26032 10.1371/journal.pone.0026032
12. C. Pettersson, H. Karlsoon, M. Stahlman, T. Larsson, B. Fagerberg, and M. Lindahl LDL-associated apolipoprotein J and lysozime are associated with atherogenic properties of LDL found in the type 2 diabetes and the metabolic syndrome J Intern Med 269 2011 306 321
13. K.N. Aronis, Y.B. Kim, and C.S. Mantzoros Clusterin (apolipoprotein J): wither link with diabetes and cardiometabolic risk? Metabolism 60 2011 747 748
14. H.R. Yu, H.C. Kuo, E.Y. Huang, C.D. Liang, K.P. Hwang, and I.C. Lin Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease Pediatr Cardiol 31 2010 1151 1156
15. T. Kujiraoka, H. Hattori, Y. Miwa, M. Ishihara, T. Ueno, and J. Ishii Serum apolipoprotein J in health, coronary heart disease and type 2 diabetes mellitus J Atheroscler Thromb 13 2006 314 322
16. V. Devauchelle, A. Essabbani, G. de Pinieux, S. Germain, L. Tourneur, and S. Mistou Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis J Immunol 177 2006 6471 6479
17. T. Calandra, and T. Roger Macrophage migration inhibitory factor: a regulator of innate immunity Nat Rev Immunol 3 2003 791 800
18. M. Leech, C. Metz, P. Hall, P. Hutchinson, K. Gianis, and M. Smith Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids Arthritis Rheum 42 1999 1601 1608
19. S. Stosic-Grujicic, I. Stojanovic, and F. Nicoletti MIF in autoimmunity and novel therapeutic approaches Autoimmun Rev 8 2009 244 249
20. A. Foote, E.M. Briganti, Y. Kipen, L. Santos, M. Leech, and E.F. Morand Macrophage migration inhibitory factor in systemic lupus erythematosus J Rheumatol 31 2004 268 273
21. E. Sánchez, L.M. Gómez, M.A. Lopez-Nevot, M.A. González-Gay, J.M. Sabio, and N. Ortego-Centeno Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus Genes Immun 7 2006 433 436
22. G. Grieb, M. Merk, J. Bernhagen, and R. Bucala Macrophage migration inhibitory factor (MIF): a promising biomarker Drug News Perspect 23 2010 257 264
23. T. Shimizu, J. Nishihira, Y. Mizue, H. Nakamura, R. Abe, and H. Watanabe High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis J Invest Dermatol 116 2001 989 990
24. H. Kim, S. Lee, H.J. Kim, M.H. Kong, Y.R. Kim, and S.H. Kang Elevated levels of macrophage migration inhibitory factor in women with metabolic syndrome Horm Metab Res 43 2011 642 645
25. S.C. Gillever, E. Emmerson, J. Bernhagen, and M.J. Hardman MIF: a key player in cutaneous biology and wound healing Exp Dermatol 20 2011 1 6
26. S. Garcia-Rodriguez, S. Arias-Santiago, R. Perandrés-López, L. Castellote, E. Zumaquero, and P. Navarro Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis J Eur Acad Dermatol Venereol. 27 2012 242 250
27. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
28. S. Arias-Santiago, J. Orgaz-Molina, L. Castellote-Caballero, M.A. Arrabal-Polo, S. Garcia-Rodriguez, and R. Perandrés-López Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis Eur J Dermatol 22 2012 337 344
29. Y.F. Cheung, T.C. Yung, S.C. Tam, M.H. Ho, and A.K. Chau Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis J Am Coll Cardiol 43 2004 120 124
30. Y. Ishikawa, Y. Akasaka, T. Ishii, K. Komiyama, S. Masuda, and N. Asuwa Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta Arterioscler Thromb Vasc Biol 18 1998 665 672